IRIS Accounts Production v23.3.1.45 09781184 Board of Directors 1.10.22 30.9.23 30.9.23 false true false false true false 89871 12312 95530 117408 115176 39849 70225 89871 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh097811842022-09-30097811842023-09-30097811842022-10-012023-09-30097811842021-09-30097811842021-10-012022-09-30097811842022-09-3009781184ns10:Originalns15:EnglandWales2022-10-012023-09-3009781184ns14:PoundSterlingns10:Original2022-10-012023-09-3009781184ns10:Originalns10:Director12022-10-012023-09-3009781184ns10:Original2022-10-012023-09-3009781184ns10:Original2023-09-3009781184ns10:Originalns10:PrivateLimitedCompanyLtd2022-10-012023-09-3009781184ns10:Originalns10:SmallEntities2022-10-012023-09-3009781184ns10:Originalns10:AuditExempt-NoAccountantsReport2022-10-012023-09-3009781184ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-10-012023-09-3009781184ns10:SmallCompaniesRegimeForAccountsns10:Original2022-10-012023-09-3009781184ns10:Originalns10:FullAccounts2022-10-012023-09-3009781184ns10:Original42ns10:Director22022-09-3009781184ns10:Original42ns10:Director22021-09-3009781184ns10:Original42ns10:Director22022-10-012023-09-3009781184ns10:Original42ns10:Director22021-10-012022-09-3009781184ns10:Original42ns10:Director22023-09-3009781184ns10:Original42ns10:Director22022-09-3009781184ns10:Originalns10:Director22022-10-012023-09-3009781184ns10:Originalns10:RegisteredOffice2022-10-012023-09-3009781184ns10:Original2022-09-3009781184ns10:Originalns5:CurrentFinancialInstruments2023-09-3009781184ns10:Originalns5:CurrentFinancialInstruments2022-09-3009781184ns10:Originalns5:Non-currentFinancialInstruments2023-09-3009781184ns10:Originalns5:Non-currentFinancialInstruments2022-09-3009781184ns5:ShareCapitalns10:Original2023-09-3009781184ns5:ShareCapitalns10:Original2022-09-3009781184ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-09-3009781184ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-09-3009781184ns10:Original2021-10-012022-09-3009781184ns10:Originalns5:ComputerEquipment2022-09-3009781184ns10:Originalns5:ComputerEquipment2022-10-012023-09-3009781184ns10:Originalns5:ComputerEquipment2023-09-3009781184ns10:Originalns5:ComputerEquipment2022-09-3009781184ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-09-3009781184ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-09-3009781184ns10:Original1ns10:Director12022-09-3009781184ns10:Original1ns10:Director12021-09-3009781184ns10:Original1ns10:Director12022-10-012023-09-3009781184ns10:Original1ns10:Director12021-10-012022-09-3009781184ns10:Original1ns10:Director12023-09-3009781184ns10:Original1ns10:Director12022-09-30
REGISTERED NUMBER: 09781184 (England and Wales)






















Unaudited Financial Statements

for the Year Ended 30 September 2023

for

Peslocus Healthcare Limited

Peslocus Healthcare Limited (Registered number: 09781184)






Contents of the Financial Statements
for the year ended 30 September 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Peslocus Healthcare Limited

Company Information
for the year ended 30 September 2023







DIRECTORS: Mr O Oyeleye
Mrs O Oyeleye





REGISTERED OFFICE: 5 Waltham Road
Boreham
Chelmsford
Essex
CM3 3AS





REGISTERED NUMBER: 09781184 (England and Wales)





ACCOUNTANTS: Bennett Brooks & Co Ltd
Chartered Accountants
14 Grosvenor Court
Foregate Street
Chester
Cheshire
CH1 1HG

Peslocus Healthcare Limited (Registered number: 09781184)

Balance Sheet
30 September 2023

2023 2022
Notes £ £
FIXED ASSETS
Tangible assets 4 1,178 1,081

CURRENT ASSETS
Debtors 5 71,421 91,627
Cash at bank 7,085 15,778
78,506 107,405
CREDITORS
Amounts falling due within one year 6 (23,481 ) (23,547 )
NET CURRENT ASSETS 55,025 83,858
TOTAL ASSETS LESS CURRENT
LIABILITIES

56,203

84,939

CREDITORS
Amounts falling due after more than one year 7 (8,333 ) (12,333 )

PROVISIONS FOR LIABILITIES (294 ) (200 )
NET ASSETS 47,576 72,406

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 47,476 72,306
47,576 72,406

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 January 2024 and were signed on its behalf by:





Mr O Oyeleye - Director


Peslocus Healthcare Limited (Registered number: 09781184)

Notes to the Financial Statements
for the year ended 30 September 2023

1. STATUTORY INFORMATION

Peslocus Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of services provided in the period, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

Peslocus Healthcare Limited (Registered number: 09781184)

Notes to the Financial Statements - continued
for the year ended 30 September 2023

4. TANGIBLE FIXED ASSETS
Computer
equipment
£
COST
At 1 October 2022 3,783
Additions 490
At 30 September 2023 4,273
DEPRECIATION
At 1 October 2022 2,702
Charge for year 393
At 30 September 2023 3,095
NET BOOK VALUE
At 30 September 2023 1,178
At 30 September 2022 1,081

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£ £
Other debtors 71,421 91,627

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£ £
Bank loans and overdrafts 4,000 4,000
Taxation and social security 16,829 17,021
Other creditors 2,652 2,526
23,481 23,547

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£ £
Bank loans 8,333 12,333

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 September 2023 and 30 September 2022:

2023 2022
£ £
Mr O Oyeleye and Mrs O Oyeleye
Balance outstanding at start of year 89,871 12,312
Amounts advanced 95,530 117,408
Amounts repaid (115,176 ) (39,849 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 70,225 89,871

Included within other debtors is £70,225 (2022 £89,871) owed to the company from both Mr O Oyeleye and Mrs O Oyeleye. The amount is unsecured, interest free and repayable on demand.

During the year dividends totalling £90,000 (2022 £16,500) were paid to the directors.

Peslocus Healthcare Limited (Registered number: 09781184)

Notes to the Financial Statements - continued
for the year ended 30 September 2023

9. ULTIMATE CONTROLLING PARTY

During the year ended 30 September 2023 the directors Mr O and Mrs O Oyeleye, controlled the company by virtue of owning all of the issued share capital.